Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy - Top-Institutions - MDSpire

Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy

  • By

  • Anita Muglia

  • Daniele Petrone

  • Ilaria Schiavoni

  • Letizia Santinelli

  • Pasqualina Leone

  • Antonino Bella

  • Gabriella d’Ettorre

  • Francesco Alessandri

  • Anna Teresa Palamara

  • Claudio Maria Mastroianni

  • Paola Stefanelli

  • Giorgio Fedele

  • May 25, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Umberto I Hospital
    Umberto I Hospital

    Rome, Lazio

    Key Differentiators

    • Infectious Disease

  • #2

    Sapienza University of Rome
    Sapienza University of Rome

    Rome, Lazio

    Key Differentiators

    • Infectious Disease

  • #3

    Istituto Superiore di Sanità
    Istituto Superiore di Sanità

    Rome, Lazio

    Key Differentiators

    • Infectious Disease

  • #4

    San Raffaele Scientific Institute
    San Raffaele Scientific Institute

    Milan, Lombardy

    Key Differentiators

    • Infectious Disease

Original Source(s)

Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy

  • by Anita Muglia, Daniele Petrone, Ilaria Schiavoni, Letizia Santinelli, Pasqualina Leone, Antonino Bella, Gabriella d’Ettorre, Francesco Alessandri, Anna Teresa Palamara, Claudio Maria Mastroianni, Paola Stefanelli, Giorgio Fedele

  • May 25, 2026

Related Content

Explainable machine learning-based mortality risk stratification for older adults with COVID-19: pinpointing core immunological biomarkers and revealing dose-threshold effects

Long-term epidemiological patterns of pediatric infectious diseases in an urban district of Shanghai, 2015–2023

Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis